Home > Insider Trading > Filing (0001127602-21-012256)

Filing Details

Accession Number:: 0001127602-21-012256
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-03-29 18:53:05
Reporting Period:: 2021-03-26

Accepted Time:: 2021-03-29 18:53:05
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
64803	Cvs Health Corp	CVS	Retail-Drug Stores And Proprietary Stores (5912)	050494040

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1194413	J Larry Merlo	One Cvs Drive Woonsocket RI 02895-		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-03-26	271,347	$74.29	794,676	No	4	M	Direct
Common Stock	Disposition	2021-03-26	270,650	$74.73	524,026	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2021-03-26	271,347	$0.00	271,347	$74.29

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2015-04-01	2021-04-01	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	406,633	Indirect	By Trust As Beneficiary
Common Stock (Restricted)	40,701	Direct
Esop Common Stock	7,548	Indirect	By ESOP
Stock Unit	688,686	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Phantom Stock Credits	$1.00			5,153	5,153	Direct
Common Stock	Stock Option	$102.26	2016-04-01	2022-04-01	273,929	273,929	Direct
Common Stock	Stock Option	$104.82	2017-04-01	2023-04-01	286,787	286,787	Direct
Common Stock	Stock Option	$78.05	2018-04-03	2024-04-03	338,105	338,105	Direct
Common Stock	Stock Option	$62.21	2019-04-01	2025-04-01	394,091	394,091	Direct
Common Stock	Stock Option	$54.19	2020-04-01	2029-04-01	545,419	545,419	Direct
Common Stock	Stock Option	$58.34	2021-04-01	2030-04-01	478,711	478,711	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	5,153	5,153	Direct
2022-04-01	273,929	273,929	Direct
2023-04-01	286,787	286,787	Direct
2024-04-03	338,105	338,105	Direct
2025-04-01	394,091	394,091	Direct
2029-04-01	545,419	545,419	Direct
2030-04-01	478,711	478,711	Direct

Footnotes

All sales were effected pursuant to a Rule 10b5-1 Plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the Reporting Person retaining all remaining shares.
Represents weighted average sale prices for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $74.49 and $75.73 per share.
Option became exercisable in four equal annual installments, commencing 4/1/2015.
Each share credit is equivalent to one share; 1-for-1 conversion.
Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
Option became exercisable in four equal annual installments, commencing 4/1/2016.
Option became exercisable in four equal annual installments, commencing 4/1/2017.
Option became exercisable in four equal annual installments, commencing 4/3/2018.
Option became exercisable in four equal annual installments, commencing 4/1/2019.
Option became exercisable in four equal annual installments, commencing 4/1/2020.
The number of shares subject to the option were calculated using a 30-day average price.
Option becomes exercisable in four equal annual installments, commencing 4/1/2021.